BRCA Hereditary Breast Carcinoma — Trials

BRCA Hereditary Breast Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

7 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Fudan University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05485766	Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer	recruiting	Phase 2	23	Okayama UniversityOTHER	1	Mar 20, 2025	clinicaltrials
NCT06516289	Neoadjuvant Treatment of gBRCA-Mutated HER2-Negative Breast Cancer With HRS-1167 and Famitinib ± Camrelizumab	recruiting	Phase 2	130	Fudan UniversityOTHER	1	Dec 12, 2024	clinicaltrials